AbbVie and FutureGen Enter License Agreement for Advanced Inflammatory Bowel Disease Therapy

Roche's PD-L1 Assay Receives Expanded CE Mark as Companion Diagnostic for Libtayo in Combination with Chemotherapy

Indian TB Diagnostic Technology Receives Praise at World Health Assembly

FDA Grants Accelerated Approval to Augtyro™ (Repotrectinib) for NTRK-Positive Locally Advanced or Metastatic Solid Tumors

QIAGEN ‘s QCI Interpret Software Enhances Clinical Reporting Speed for High-Throughput NGS Testing Labs

Approval Granted: Applied DNA's TR8(TM) Pharmacogenomic (PGx) Testing Service Receives Green Light from New York State Department of Health

Sirnaomics Unveils Robust Antitumor Efficacy of Novel Oligonucleotide-ChemoDrug Conjugate in Journal of Oncology Research and Therapy

QIAGEN Introduces Advanced QIAcuity Digital PCR Assays for Microbial Studies, Elevating Infectious Disease Research and Surveillance

DRAGEN v4.3 by Illumina: Advancing the Most Comprehensive and Accurate Genome with Cutting-Edge Innovations

Transforming Healthcare: The Rise of Genomic Urine Testing

Myriad Genetics Partners with GSK to Enhance HRD Testing Accessibility Across Nine Nations

Unveiling the Future of Cancer Care: Join Diaceutics' Virtual Event on Precision Medicine in Oncology

FDA Clears Abbott's Over-the-Counter Continuous Glucose Monitors

FDA Prioritizes AstraZeneca's Tagrisso sNDA for Priority Review in Unresectable Stage III NSCLC

Advancements in Biomarkers for Early Cancer Detection